Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$6.38 - $9.3 $4.42 Million - $6.45 Million
-693,542 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$8.68 - $16.99 $31,248 - $61,163
3,600 Added 0.52%
693,542 $6.76 Million
Q1 2021

May 17, 2021

BUY
$13.75 - $23.86 $642,702 - $1.12 Million
46,742 Added 7.27%
689,942 $10.9 Million
Q4 2020

Feb 16, 2021

SELL
$16.97 - $25.34 $7,161 - $10,693
-422 Reduced 0.07%
643,200 $15.6 Million
Q3 2020

Nov 16, 2020

BUY
$16.76 - $31.89 $10.8 Million - $20.5 Million
643,622 New
643,622 $10.8 Million

Others Institutions Holding TARA

About Protara Therapeutics, Inc.


  • Ticker TARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,267,400
  • Market Cap $25.8M
  • Description
  • Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...
More about TARA
Track This Portfolio

Track Rock Springs Capital Management LP Portfolio

Follow Rock Springs Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.